The rise of cardiovascular medicine

European Heart Journal

Volumn 33, Issue 7, 2012, Pages

  Braunwald, Eugene ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Arrhythmias; Heart failure; Myocardial infarction

Indexed keywords

ALDOSTERONE ANTAGONIST; BENZOTHIADIAZINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT; HYDRALAZINE; LOOP DIURETIC AGENT; MILRINONE; NITRATE; STREPTOKINASE; VASODILATOR AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; CARDIAC IMAGING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOLOGY; CARDIOVASCULAR SYSTEM; CORONARY CARE UNIT; CORONARY RISK; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; EVIDENCE BASED PRACTICE; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART FAILURE; HEART SURGERY; HISTORY OF MEDICINE; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; MORTALITY; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REPERFUSION; REVIEW; SPHYGMOMANOMETRY; VALVULAR HEART DISEASE; X RAY;

BALLOON DILATION; CARDIAC IMAGING TECHNIQUES; CARDIOLOGY; CORONARY CARE UNITS; ELECTROCARDIOGRAPHY; FORECASTING; GENE THERAPY; HEART CATHETERIZATION; HEART DISEASES; HEART-ASSIST DEVICES; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; PERIODICALS AS TOPIC; SOCIETIES, MEDICAL; STEM CELL TRANSPLANTATION; THORACIC SURGERY;

EID: 84859514837     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr452     Document Type: Review

References (65)

1. Veith I. Huang Ti Nei Ching Su Wen - The Yellow Emperor's Classic of Internal Medicine. Berkeley, Los Angeles: University of California Press; 1986, p260.
2. Harvey W. An anatomical disputation concerning the movement of the heart and blood in living creatures. Translation by Whitteridge G. Oxford: Blackwell Scientific Publications; 1976, pp1-135.
3. Heberden W. Some account of a disorder of the breast. Med Trans 1772;2:59-67.
4. Warren J. Remarks on angina pectoris. N Engl J Med 1812;1:1-11.
5. Roentgen WC. On a new kind of rays. Gesellschaft: Sitzungsberichte der Wurzburgery Physik-medic, 1895.
6. Einthoven W. Galvonometrische registratie van het menschelijk electrocardiogram. In: Herinneringsbundel Professor S. S. Rosenstein. Leiden: Edouard Ijdo; 1902. pp101-107.
7. Krehl L. Die Ekrankungen des Herzmuskels und die Nervosen Herzkrankheiten. Vienna: Alfred Holder; 1901.
8. Obrastzov WP, Straschesko ND. Zur kenntnis der thrombose der koronararterien des herzens. Z Klin Med 1910;71:116-132.
9. Herrick JB. Certain clinical features of sudden obstruction of the coronary arteries. JAMA 1912;59:2015-2020.
10. Herrick JB. Thrombosis of the coronary arteries. JAMA 1919;72:387-390.
11. Anitschkow N, Chalatow S. On experimental cholesterin steatosis and its significance in the origin of some pathological processes. Translated by Maria Z. Pelias. ATVB 1983;3:178-182. (Pubitemid 13136504)
12. Forssman W. Catheterization of the right heart. Klin Wochenshr 1929;8: 2085-2087.
13. Cournand AF, Ranges HS. Catheterization of the right auricle in man. Proc Soc Exp Biol Med 1941;46:462-466.
14. Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979;301:61-68. (Pubitemid 9229695)
15. Julian DG. Treatment of cardiac arrest in acute myocardial ischemia and infarction. Lancet 1961;ii:840-844.
16. Fye WB. Resuscitating a Circulation abstract to celebrate the 50th anniversary of the coronary care unit concept. Circulation 2011;124:1886-1893.
17. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J Jr, Braunwald E. Factors influencing infarct size following experimental coronary artery occlusion. Circulation 1971;43:67-82.
18. Chazov EI, Mateeva LS, Mazaev AV. Intracoronary administration of fibrinolysin in acute myocardial infarction. Ter Arkh 1976;48: 8-19.
19. Rentrop KP, Blanke H, Karsch KR, Wiegand V, Köstering H, Oster H, Leitz K. Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase. Clin Card 1979;2:354-63. (Pubitemid 10181856)
20. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
21. ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;1:349-360.
22. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-684. (Pubitemid 23073369)
23. Zhu MM, Feit A, Chadow H, Alam M, Kwan T, Clark LT. Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction. A meta analysis of randomized clinical trials. Am J Cardiol 2001;88:297-301. (Pubitemid 32721960)
24. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rutherford J, Wertheimer JH, Hawkins CM; on behalf of the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. SAVE TRIAL. N Engl J Med 1992;327: 669-677.
25. Braunwald E. Unstable angina-A classification. Circulation 1989;80:410-414.
26. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E; for the FRISC II Investigators. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomized trial. Lancet 2000;356:9-16. (Pubitemid 30416988)
27. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887. (Pubitemid 32564900)
28. Edler I, Hertz CH. Use of ultrasonic reflectoscope for the continuous recording of movements of heart walls. Kungl Fysiografiska Sallskapets i Lund Forhandlingar 1954;24:40-58.
29. Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954;37:171-175.
30. DeBakey M, Garrett HE, Dennis EW. Aorto-coronary bypass with saphenous vein graft. Seven-year follow-up. JAMA 1973;223:792.
31. Favaloro RG. Saphenous vein graft in the surgical treatment of coronary artery disease. Operative technique. J Thorac Cardiovasc Surg 1969;58:178-85.
32. Zoll PM. Resuscitation of the heart in ventricular standstill by external electrical stimulation. N Engl J Med 1952;247:768-771.
33. Elmqvist R. Review of early pacemaker development. PACE 1978;1:535-536. (Pubitemid 9122040)
34. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-324. (Pubitemid 10040022)
35. Haissaguerre M, Jais P, Shah DC, Garrigue S, Takahasi A, Lavergne T, Hocini M, Peng JT, Roudaut R, Clementy J. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000;101:1409-1417. (Pubitemid 30169863)
36. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ. Transcatheter versus surgical aortic valve replacement in high-risk patients. N Engl J Med 2011;364:2187-2198.
37. Novello SC, Sprague JM. Benzothiadiazine dioxides as novel diuretics. J Am Chem Soc 1957;79:2028.
38. Kagawa CM, Sturtevant FM, van Arman CG. Pharmacology of a new steroid that blocks salt activity of aldosterone and desoxycorticosterone. J Pharm Exp Ther 1959;126:123-130.
39. Schultz EM, Chragoe EJ, Bicking JB, Bolhofer WA, Sprague JM. α,β-Unsaturated ketone derivatives of arloxyacetic acids, a new class of diuretics. J Med Pharm Chem 1962;5:642-646.
40. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986;314:1547-1552. (Pubitemid 16114684)
41. The CONSENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-1435.
42. Waagstein F, Hjalmarson A, Swedeberg K, Wallentin I. Beta-blockers in dilated cardiomyopathies: they work. Eur Heart J 1983;4:173-178. (Pubitemid 13137344)
43. Barnard CN. The operation. S Afr Med J 1967;41:1271.
44. Cazeau S, Ritter P, Lazarus A, Gras D, Backdach H, Mundler O, Mugica J. Multisite pacing for end-stage heart failure: early experience. Pacing Clin Electrophysiol 1996; 19:1748-1757. (Pubitemid 26398444)
45. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Third INTERMACS annual report: the evolution of destination therapy in the United States. J Heart Lung Transplant 2011;30: 115-123.
46. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd. Factors of risk in the development of coronary heart disease - six-year follow-up experience. The Framingham Study. Ann Int Med 1961;55:33-50.
47. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simbastatin Survival Study. Lancet 1994;344:1383-1389.
48. Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a metaanalysis of data from 170 000 participants in 26 randomised trials. Lancet 2010;376:1670-1681.
49. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207.
50. Endo A, Kuroda M, Tsujita Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum. J Antibiot (Jpn) 1976;29: 1346-1348. (Pubitemid 8018023)
51. Medical Research Council Streptomycin in Tuberculosis Trials Committee. Streptomycin treatment for pulmonary tuberculosis. BMJ 1948;ii:769-782.
52. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect on encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321: 406-412.
53. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMets DL; The PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991;325:1468-1475.
54. Antman EM. Evidence and education. Circulation 2011;123:681-685.
55. Holmes DR Jr. The Global College of Cardiology: it's a small world after all. J Am Coll Cardiol 2011;58:194-195.
56. Braunwald E. Departments, divisions and centers in the evolution of medical schools. Am J Med 2006;119:457-462. (Pubitemid 43810151)
57. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011;123:933-944.
58. Lonn E, Bosch J, Teo KK, Pais P, Xavier D, Yusuf S. The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions. Circulation 2010;122:2078-2088.
59. Segers VFM, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008;451: 937-942. (Pubitemid 351301749)
60. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872. (Pubitemid 350138099)
61. Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM, Dittrich H, Hajjar RJ. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID). A phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 2011;124:304-313.
62. Myocardial Infarction Genetics Consortium. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009;41:334-341.
63. Sucharov C, Bristow MR, Port JD. miRNA expression in the failing human heart: functional correlates. J Mol Cell Biol 2008;45:185-192.
64. Suckau L, Fechner H, Chemaly E, Krohn S, Hadri L, Kockskämper J, Westermann D, Bisping E, Ly H, Wang X, Kawase Y, Chen J, Liang L, Sipo I, Vetter R, Weger S, Kurreck J, Erdmann V, Tschope C, Pieske B, Lebeche D, Schultheiss HP, Hajjar RJ, Poller WC. Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation 2009;119:1241-1252.
65. Weintraub WS, Daniels SR, Burke LE, Franklin BA, Goff DC Jr, Hayman LL, Lloyd-Jones D, Pandey DK, Sanchez EJ, Schram AP, Whitsel LP; on behalf of the American Heart Association Advocacy Coordinating Committee. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation 2011;124:967-990.